Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials 2 (HIPACT 2)

夏威夷 IDeA 儿科和青少年临床试验中心 2 (HIPACT 2)

基本信息

批准号：
10685355
负责人：
Venkataraman Balaraman
金额：
$ 25万
依托单位：
UNIVERSITY OF HAWAII AT MANOA
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-23 至 2025-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10685355
关键词：
Achievement Adolescent Alaska Native American Indians Area Asian population Black Populations Burn injury Child Child Health Childhood Clinic Clinical Trials Clinical Trials Network Communities Development Discipline of obstetrics Environment Environmental Science Ethnic Population Faculty Funding Geography Goals Gynecology Hawaii Hawaiian Hawaiian population Health Hispanic Populations Home Immersion Immigrant Indigenous Infant Institution Leadership Maternal-fetal medicine Medical center Mentors Multi-Institutional Clinical Trial Native Hawaiian or Other Pacific Islander Nursing Faculty Obesity Outcome Pacific Islander Pediatric Research Perinatal Personal Satisfaction Population Productivity Research Research Personnel Role Rural Rural Community Scholars Program Site Taxes Teacher Professional Development Traction Training and Education Trust Universities Woman base clinical research site faculty research health inequalities health outcome disparity improved innovation interest invention medical schools multi-ethnic neurodevelopment pediatric department postnatal prenatal programs rural area socioeconomics success underserved area underserved community

项目摘要

ABSTRACT The principal objective of this second cycle of Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials2 (HIPACT2) is to capitalize on the success of the first fouryears of HIPACT as a productive and engaged Environmental Influences of Child Health Outcomes IDeA States Pediatric Clinical Trials Network (ECHO ISPCTN) site. The first four years of HIPACT launched ECHO ISPCTN clinical trials, engaged new junior investigators in ECHO ISPCTN endeavors and built pediatric clinical trials capacity at HIPACT's partner institutions. As a relatively small ECHO ISPCTN site with a historical paucity of pediatric involvement in clinical trials, HIPACT successfully inspired and engaged new junior faculty across the spectrum of professional development activities. The initial success of HIPACT spirited the momentum for academic and community efforts to participate fully in the planning of HIPACT2 including newly committed partners. We have established a mechanism to participate in HIPACT2 by engaging pediatric and maternal-fetal medicine faculty through the Hawaii Pediatric Research (HIPR) Scholars Program. Moreover, we will endeavor to feed into the pipeline of ECHO ISPCTN activities with the goal of increasing the number of junior faculty involved in HIPACT2. With the overarching goal to improve the health and wellbeing of the diverse multiethnicpopulations in rural and underserved areas of Hawaii including indigenous Hawaiian communities, and immigrant populations of Pacific Islanders and Asians, HIPACT2will capitalize on established HIPACT partnerships with Hawaii Pacific Health (HPH) Kapiolani Medical Center for Women and Children (KMCWC), and Waianae Coast Comprehensive Health Center (WCCHC). The following Specific Aims are proposed: Aim 1: To actively contribute to and participate in ECHO ISPCTN pediatric clinical trials; Aim 2: To provide access to clinical trials to benefit rural and underserved infants, children, and adolescents, many of who are Native Hawaiians, Pacific Islanders, and Asians; Aim 3: To participate in the “science” of ECHO ISPCTN multicenter clinical trials research; Aim 4: To mentor a cadre of junior faculty via the Hawaii Pediatric Research (HIPR) Scholars Program. Taken together, HIPACT2 will act as an eager partner in ECHO ISPCTN in this second five-year cycle of funding with a strong historical track record of engagement and achievement, institutional support, and newly committed partners. It will enrich opportunities for faculty research training and education, participation in collaborative multicenter clinical trial research, and engage rural and underserved communities to improve health outcomes in Hawaii and across the nation.

抽象的夏威夷 IDeA 儿科和青少年临床试验中心第二轮的主要目标2 (HIPACT2) 旨在利用 HIPACT 前四年的成功作为富有成效和敬业度的组织环境对儿童健康结果的影响 IDeA 国家儿科临床试验网络 (ECHO ISPCTN）网站。HIPACT 的前四年推出了 ECHO ISPCTN 临床试验，招募了新的初级人员。 ECHO ISPCTN 的研究人员努力并在 HIPACT 的合作伙伴中建立了儿科临床试验能力作为一个相对较小的 ECHO ISPCTN 站点，历史上很少有儿科参与临床。试验中，HIPACT 成功地激发并吸引了各个专业领域的新初级教师 HIPACT 的初步成功为学术界和社区注入了活力。我们已确定充分参与 HIPACT2 的规划工作，包括新承诺的合作伙伴。通过让儿科和母胎医学教师参与 HIPACT2 的机制此外，我们将努力纳入夏威夷儿科研究 (HIPR) 学者计划。 ECHO ISPCTN 活动的目标是增加参与 HIPACT2 的初级教师数量。改善农村和地区不同多民族人口的健康和福祉的总体目标夏威夷服务不足的地区，包括夏威夷土著社区和太平洋移民人口岛民和亚洲人，HIPACT2 将利用与 Hawaii Pacific Health 建立的 HIPACT 合作伙伴关系 (HPH) 卡皮奥拉尼妇女儿童医疗中心 (KMCWC) 和怀厄奈海岸综合健康中心中心 (WCCHC) 提出以下具体目标：目标 1：积极贡献和参与 ECHO ISPCTN 儿科临床试验；目标 2：提供临床试验机会，使农村和服务不足的地区受益婴儿、儿童和青少年，其中许多是夏威夷原住民、太平洋岛民和亚洲人；目标 3：参与ECHO ISPCTN多中心临床试验研究的“科学”；目标4：指导骨干通过夏威夷儿科研究 (HIPR) 学者计划，HIPACT2 将充当初级教师的角色。在第二个五年融资周期中，ECHO ISPCTN 的热心合作伙伴，拥有良好的历史记录参与和成就、机构支持和新承诺的合作伙伴将丰富机会。用于教师研究培训和教育，参与协作多中心临床试验研究，以及让农村和服务欠缺的社区参与进来，改善夏威夷和全国的健康状况。

项目成果

期刊论文数量（1）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Pediatric Code Blue: How Prepared Are We? A Self-Efficacy Assessment Project.

儿科蓝色代码：我们准备得如何？

DOI：
发表时间：
2020
期刊：
影响因子：
0
作者：
Purohit, Prashant J;Yamamoto, Laurie;Tanaka, Len Y;Xoinis, Konstantine;Harrington, John;Chang, Rupert;Feng, Andrew
通讯作者：
Feng, Andrew